# TEF

## Overview
The TEF gene encodes the Thyrotroph Embryonic Factor, a transcription factor that is part of the PAR bZIP family, characterized by a basic leucine zipper (bZIP) domain. This domain is crucial for DNA binding and dimerization, allowing TEF to regulate gene expression by forming homodimers or heterodimers with other proteins. The TEF protein is involved in various physiological processes, including the development of thyrotrophs in the anterior pituitary during embryogenesis and the regulation of genes related to metabolism and detoxification in adult tissues (Drolet1991TEF; Gachon2007Physiological). TEF's role extends to interactions with other transcription factors, such as the hepatic leukemia factor (HLF) and the basic helix-loop-helix zipper protein Max, influencing gene expression in multiple tissues (Hunger1996The; Gupta1997Transcription). Clinically, variations in the TEF gene have been associated with neuropsychiatric and neurological conditions, including posttraumatic stress symptoms, Parkinson's disease, and epilepsy, highlighting its significance in human health (Linnstaedt2018Evaluation; Hua2021Thyrotroph; Gachon2004The).

## Structure
The TEF (Thyrotroph Embryonic Factor) protein is a member of the PAR bZIP family, characterized by a basic leucine zipper (bZIP) domain that facilitates DNA binding and dimerization. The bZIP domain includes a leucine zipper motif, a helical region with leucine residues at every seventh position, which is essential for forming homodimeric or heterodimeric proteins (Drolet1991TEF). TEF shares a unique homology with the albumin D box-binding protein (DBP), and both can form heterodimers (Drolet1991TEF).

The protein structure includes a major trans-activation domain located at the amino-terminal region, specifically between amino acids 7-123, which is crucial for its transcriptional activity (Drolet1991TEF). TEF also contains a proline-and acidic amino acid-rich (PAR) domain, which is associated with transcriptional activation (Inukai2005TEF). The basic domain (amino acids 176-218) and the leucine zipper domain (amino acids 219-255) are crucial for DNA-binding activity (Drolet1991TEF).

TEF proteins may undergo post-translational modifications such as phosphorylation, which can influence their activity and stability (Inukai2005TEF). The protein's ability to form dimers is essential for its function as a transcription factor, with the leucine zipper domain playing a critical role in this process (Drolet1991TEF).

## Function
The thyrotroph embryonic factor (TEF) is a transcription factor belonging to the PAR bZIP family, which plays a significant role in regulating gene expression in various physiological processes. TEF is specifically expressed in the anterior pituitary during embryogenesis, where it is involved in the development of thyrotrophs, cells responsible for producing thyroid-stimulating hormone (TSH) (Drolet1991TEF). TEF can bind to and trans-activate the TSH promoter, indicating its role in activating TSH gene expression (Drolet1991TEF).

TEF is characterized by a leucine zipper motif that facilitates dimerization, a common feature among bZIP proteins, which is essential for its DNA-binding activity (Drolet1991TEF). It can form homodimers or heterodimers with other proteins like DBP, allowing it to regulate gene expression in different tissues (Drolet1991TEF). TEF's trans-activation domain, located between amino acids 7-123, is crucial for stimulating gene activity, particularly in pituitary-specific promoters (Drolet1991TEF).

In adult tissues, TEF is expressed in various organs, including the liver, heart, and brain, suggesting a broader role in regulating gene expression beyond embryogenesis (Drolet1991TEF). It is involved in regulating genes related to metabolism and detoxification, playing a role in controlling vitamin B6 metabolism and detoxifying enzymes (Gachon2007Physiological).

## Clinical Significance
Mutations and alterations in the TEF gene have been implicated in several neuropsychiatric and neurological conditions. The TEF rs5758324 variant is associated with posttraumatic stress symptoms (PTSS), with individuals carrying the minor allele experiencing higher PTSS severity in a stress-dependent manner. This variant influences TEF mRNA expression, which correlates with PTSS severity, suggesting a gene-environment interaction where stress exacerbates symptoms in those with the variant (Linnstaedt2018Evaluation).

In Parkinson's disease (PD), the TEF rs738499 polymorphism is linked to faster progression of motor and non-motor symptoms, including sleep disturbances and depression. Carriers of the TT genotype of this polymorphism show a more rapid decline in sleep quality and motor function, indicating its potential as a genetic marker for disease prognosis (Hua2021Thyrotroph).

TEF gene mutations also play a role in epilepsy. Mice deficient in TEF, along with other PAR bZIP proteins, exhibit increased seizure susceptibility and altered EEG activity, highlighting the gene's critical role in regulating seizure susceptibility (Gachon2004The). These findings underscore the clinical significance of TEF gene mutations and expression alterations in various disorders.

## Interactions
The TEF transcription factor, a member of the PAR bZIP family, engages in several interactions with other proteins and nucleic acids. TEF can form heterodimers with the hepatic leukemia factor (HLF), sharing similar DNA-binding properties and binding to the same consensus sequences due to their structural homology (Hunger1996The). TEF also interacts with the basic helix-loop-helix zipper protein Max, which is crucial for the positive regulation of the cardiac α-myosin heavy-chain (α-MHC) gene expression. This interaction occurs in the bHLH-LZ region of Max and involves the first 180 amino acids of TEF-1, a variant of TEF (Gupta1997Transcription). The TEF-Max complex transactivates the α-MHC gene through the EM motif, highlighting a cooperative role in gene regulation (Gupta1997Transcription).

TEF is also known to bind specific nucleotide sequences within various promoters, such as the mouse TSHI3 thyrotroph-specific promoter, the rat prolactin promoter, and the rat growth hormone promoter, as demonstrated by DNase I footprinting assays (Drolet1991TEF). These interactions are mediated by the leucine zipper domain, which is essential for both homodimer and heterodimer formation, allowing TEF to regulate gene expression (Drolet1991TEF).


## References


[1. (Hunger1996The) SP Hunger, S Li, MZ Fall, L Naumovski, and ML Cleary. The proto-oncogene hlf and the related basic leucine zipper protein tef display highly similar dna-binding and transcriptional regulatory properties. Blood, 87(11):4607–4617, June 1996. URL: http://dx.doi.org/10.1182/blood.v87.11.4607.bloodjournal87114607, doi:10.1182/blood.v87.11.4607.bloodjournal87114607. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.v87.11.4607.bloodjournal87114607)

[2. (Gachon2004The) Frédéric Gachon, Philippe Fonjallaz, Francesca Damiola, Pascal Gos, Tohru Kodama, Jozsef Zakany, Denis Duboule, Brice Petit, Mehdi Tafti, and Ueli Schibler. The loss of circadian par bzip transcription factors results in epilepsy. Genes &amp; Development, 18(12):1397–1412, June 2004. URL: http://dx.doi.org/10.1101/gad.301404, doi:10.1101/gad.301404. This article has 223 citations.](https://doi.org/10.1101/gad.301404)

[3. (Drolet1991TEF) D W Drolet, K M Scully, D M Simmons, M Wegner, K T Chu, L W Swanson, and M G Rosenfeld. Tef, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes &amp; Development, 5(10):1739–1753, October 1991. URL: http://dx.doi.org/10.1101/gad.5.10.1739, doi:10.1101/gad.5.10.1739. This article has 188 citations.](https://doi.org/10.1101/gad.5.10.1739)

[4. (Gupta1997Transcription) Mahesh P. Gupta, Chirag S. Amin, Madhu Gupta, Nissim Hay, and Radovan Zak. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, max, for positive regulation of cardiac α-myosin heavy-chain gene expression. Molecular and Cellular Biology, 17(7):3924–3936, July 1997. URL: http://dx.doi.org/10.1128/mcb.17.7.3924, doi:10.1128/mcb.17.7.3924. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.7.3924)

[5. (Linnstaedt2018Evaluation) Sarah D. Linnstaedt, Yue Pan, Matthew C. Mauck, Jenyth Sullivan, Christine Y. Zhou, Lindsey Jung, Cathleen A. Rueckeis, Jameson D. Blount, Matthew S. Carson, Andrew S. Tungate, Michael C. Kurz, Phyllis L. Hendry, Christopher Lewandowski, Teresa D’Anza, Elizabeth Datner, Kathy Bell, Megan Lechner, Jeffrey W. Shupp, Bruce A. Cairns, and Samuel A. McLean. Evaluation of the association between genetic variants in circadian rhythm genes and posttraumatic stress symptoms identifies a potential functional allele in the transcription factor tef. Frontiers in Psychiatry, November 2018. URL: http://dx.doi.org/10.3389/fpsyt.2018.00597, doi:10.3389/fpsyt.2018.00597. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fpsyt.2018.00597)

[6. (Inukai2005TEF) T. Inukai. Tef, an antiapoptotic bzip transcription factor related to the oncogenic e2a-hlf chimera, inhibits cell growth by down-regulating expression of the common chain of cytokine receptors. Blood, 105(11):4437–4444, June 2005. URL: http://dx.doi.org/10.1182/blood-2004-08-2976, doi:10.1182/blood-2004-08-2976. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2004-08-2976)

[7. (Gachon2007Physiological) Frédéric Gachon. Physiological function of parbzip circadian clock‐controlled transcription factors. Annals of Medicine, 39(8):562–571, January 2007. URL: http://dx.doi.org/10.1080/07853890701491034, doi:10.1080/07853890701491034. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/07853890701491034)

[8. (Hua2021Thyrotroph) Ping Hua, Can Cui, Yong Chen, Yan Yao, Cui-Yu Yu, Li-Gang Xu, and Wei-Guo Liu. Thyrotroph embryonic factor polymorphism predicts faster progression of parkinson’s disease in a longitudinal study. Journal of Integrative Neuroscience, 20(1):95, 2021. URL: http://dx.doi.org/10.31083/j.jin.2021.01.366, doi:10.31083/j.jin.2021.01.366. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.31083/j.jin.2021.01.366)